GL1X · GenesisL1 explorer

Research workbench

Discovery of small molecule antagonists of human retinoblastoma binding protein 4 (RBBP4)

Analyse Discovery of small molecule antagonists of human retinoblastoma binding protein… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7M40
Type
protein
Length
780 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
Q09028
Ligands
YQJ

Structure

x-ray diffraction · 2 distinct chains.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein401—Q09028
B—protein379—Q09028

Ligands and binding sites

  • YQJ · N~3~-{4-[3-(dimethylamino)pyrrolidin-1-yl]-6,7-dimethoxyquinazolin-2-yl}-N~1~,N~1~-dimethylpropane-1, 3-diamine · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 7M40 · Discovery of small molecule antagonists of human Retinoblastoma Binding Protein 4 (RBBP4) · the same entry in another collection · chain A against A, TM-score 1.00
  • Q09028 · AlphaFold monomer V2.0 prediction for histone-binding protein RBBP4 (Q09028) · a predicted model of the same protein · chain B against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.